Aveanna Healthcare (AVAH) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
15 May, 2026Strategic vision and platform
Focus on transforming homecare value through a diversified, national platform serving pediatric, adult, and geriatric patients in 39 states.
Emphasis on high-quality clinical outcomes and enhanced value for payor and government partners.
Scaled national platform leverages data-driven results and value-based agreements to improve outcomes and reduce total care costs.
Investments in technology and government affairs support sustainable growth and operational efficiency.
Leadership and organizational structure
CEO, CFO, and Principal Accounting Officer have all held their roles since 2023, bringing experience from prior leadership positions in healthcare.
Leadership team has been instrumental in the formation and financial structuring of the organization.
Financial performance and guidance
2026 revenue guidance of $2.56–$2.58 billion, with a gross margin of 31.7% and adjusted EBITDA of $328–$332 million.
Q1 2026 revenue grew 15.9% year-over-year to $647.9 million, with adjusted EBITDA up 25.2% to $84.4 million.
Operating cash flow for Q1 2026 was $4.3 million, a $12.9 million improvement over the prior year.
Liquidity of $524.8 million as of April 2026, with $1.48 billion in variable rate debt and interest rate hedges in place.
Latest events from Aveanna Healthcare
- Q1 revenue and earnings surged, with raised guidance and a major pediatric care acquisition pending.AVAH
Q1 202614 May 2026 - Director elections, auditor ratification, and say-on-pay vote headline the annual meeting agenda.AVAH
Proxy filing17 Apr 2026 - Strong financial results, board elections, auditor ratification, and executive pay up for vote.AVAH
Proxy filing17 Apr 2026 - Strong revenue growth and value-based care drive expansion in a $119bn homecare market.AVAH
Investor presentation20 Mar 2026 - Double-digit revenue and profit growth in 2025, robust 2026 outlook, major acquisition announced.AVAH
Q4 202519 Mar 2026 - Q2 revenue up 7% to $505M, adjusted EBITDA up 27%, guidance raised despite lower net income.AVAH
Q2 20242 Feb 2026 - Strategic transformation and rate wins drive growth, staffing, and margin expansion in 2024.AVAH
Healthcare Services Conference1 Feb 2026 - Accelerating growth via preferred payer strategy, targeting $200M EBITDA by 2026.AVAH
Jefferies Global Healthcare Conference1 Feb 2026 - 2025 guidance raised as transformation and Q3 results drive scalable, value-based growth.AVAH
44th Annual J.P. Morgan Healthcare Conference16 Jan 2026